Premenstrual Dysphoric Disorder (PMDD) Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceDeficiency linked to PMS/PMDD symptoms; supplementation significantly reduces mood and physical symptoms
Supports serotonin and dopamine synthesis; may help reduce mood and physical symptoms
Supporting Stack
Additional supplements for enhanced resultsModulates dopamine and prolactin; improves hormonal balance and reduces PMS/PMDD symptoms
Supporting Studies (1)
Deficiency associated with PMS; supports mood, reduces fluid retention and cramps
Supporting Studies (1)
Supports serotonin signaling; may improve mood symptoms in PMDD
Supporting Studies (1)
Anti-inflammatory effects; may reduce mood and physical symptoms
Supporting Studies (1)
Deficiency associated with more severe PMS; supports mood and calcium metabolism
Supporting Studies (1)
GLA content may help with breast tenderness and mood; evidence is mixed
Supporting Studies (1)
May improve mood symptoms through serotonergic mechanisms
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome affecting 3-8% of women. It causes significant mood symptoms (depression, anxiety, irritability, mood swings), physical symptoms (bloating, breast tenderness, fatigue), and behavioral changes in the luteal phase (1-2 weeks before menstruation), with symptoms resolving after period starts. PMDD significantly impairs daily functioning, relationships, and quality of life. It's thought to involve abnormal sensitivity to normal hormonal fluctuations, affecting neurotransmitters like serotonin.
CRITICAL: PMDD is a serious condition that often requires medical treatment. First-line therapies include SSRIs (effective even when taken only during the luteal phase) and hormonal treatments (continuous oral contraceptives, GnRH agonists). If symptoms are severe, including thoughts of self-harm, seek immediate help. Track symptoms for 2+ cycles to confirm diagnosis. These supplements may provide relief for mild-moderate symptoms or complement medical treatment. Discuss with your doctor before replacing prescribed medications.
* Calcium is the best-studied supplement for PMS/PMDD. A large randomized trial showed 1200mg daily significantly reduced mood, pain, and physical symptoms. Women with PMS often have lower calcium levels.
* Vitamin B6 supports the synthesis of serotonin and dopamine - neurotransmitters involved in mood. Systematic reviews support its use for PMS symptoms, though keep doses at or below 100mg to avoid nerve toxicity.
* Vitex (Chaste Tree Berry) is a traditional herb that modulates prolactin through dopamine effects. Clinical trials show it reduces PMS symptoms, particularly breast tenderness, irritability, and mood changes.
* Magnesium deficiency is associated with PMS symptoms. Supplementation may help with mood, fluid retention, and cramps. Often combined with vitamin B6 for synergistic effects.
* Inositol supports serotonin signaling and has shown promise for PMDD mood symptoms in preliminary studies.
* Omega-3 Fatty Acids have anti-inflammatory and mood-supporting effects.
* Vitamin D deficiency is associated with more severe PMS symptoms.
* Evening Primrose Oil contains GLA and may help with breast tenderness, though evidence is mixed.
* Saffron has mood-enhancing properties and may help with PMS-related mood symptoms.
Expected timeline: Calcium effects may be seen within 2-3 cycles. Vitex typically requires 3+ cycles. Mood supplements work best with consistent daily use.
Clinical Perspective
Premenstrual Dysphoric Disorder (PMDD): DSM-5 criteria require 5+ symptoms in most cycles, at least one being mood-related (depression, anxiety, affective lability, irritability). Symptoms must be in the luteal phase, remit within days of menses, and cause significant distress/impairment. Differentiate from premenstrual exacerbation of underlying psychiatric disorder. Pathophysiology: abnormal CNS sensitivity to normal hormone fluctuations; serotonergic system particularly affected.
CRITICAL: First-line treatment: SSRIs (fluoxetine, sertraline, paroxetine, escitalopram) - can use continuous or luteal-phase only; effective for 60-70%. Second-line: combined OCPs (continuous or with shortened hormone-free interval), GnRH agonists + add-back. Severe/refractory: consider surgical menopause as last resort. CBT effective adjunct. Track symptoms 2+ cycles for diagnosis. Supplements are for mild symptoms or adjunctive use. If suicidal ideation present, urgent psychiatric care needed.
* Calcium (A-grade): Mechanism possibly related to serotonin or altered calcium homeostasis. RCT: 1200mg significantly reduced PMS symptoms (PMID: 9731851). Systematic review confirms (PMID: 28054790). 1000-1200mg daily.
* Vitamin B6 (B-grade): Cofactor for neurotransmitter synthesis. Systematic review: effective for PMS (PMID: 10190318). Meta-analysis: modest benefit (PMID: 26770644). 50-100mg daily. Don't exceed 100mg long-term (neuropathy risk).
* Vitex (B-grade): Dopaminergic; reduces prolactin. Systematic review: effective for PMS (PMID: 23637140). 20-40mg daily. Takes 3+ cycles.
* Magnesium (B-grade): Multiple mechanisms including serotonin. Clinical trial: reduced symptoms (PMID: 1786036). 200-400mg daily. Combine with B6.
* Inositol (C-grade): Second messenger; serotonin sensitivity. Pilot study: reduced PMDD symptoms (PMID: 16846587). 12-18g daily. Powder form.
* Omega-3 Fatty Acids (C-grade): Anti-inflammatory; membrane function. Clinical trial: symptom reduction (PMID: 23147110). 1-2g EPA+DHA daily.
* Vitamin D (C-grade): Calcium metabolism; mood. Systematic review: deficiency associated with PMS (PMID: 29447494). 2000-4000 IU daily.
* Evening Primrose Oil (C-grade): GLA source; prostaglandins. Systematic review: mixed evidence (PMID: 8752621). 1-3g daily. May help breast tenderness.
* Saffron (C-grade): Serotonergic effects. RCT: improved PMS symptoms (PMID: 19004341). 15-30mg daily.
Biomarker targets: Symptom tracking (DRSP, PSST scales), improvement in functional impairment, relationship quality.
Protocol notes: Prospective symptom tracking for 2+ cycles required for diagnosis - use validated tools (DRSP). Lifestyle modifications: regular aerobic exercise (strong evidence), stress management, limit salt/caffeine/alcohol. Sleep hygiene important. SSRIs most effective - can use luteal phase dosing (sertraline 50-100mg, fluoxetine 10-20mg days 14-28). For contraception + PMDD: continuous combined OCP or Yaz (drospirenone-containing with 24/4 regimen). Cognitive behavioral therapy addresses catastrophic thinking patterns. Supplements may be first-line for mild symptoms or patient preference. Calcium + magnesium + B6 is common combination. Start one supplement at a time to assess individual response. Vitex: avoid with dopamine agonists or oral contraceptives. Monitor for psychiatric emergency - PMDD increases suicide risk. Consider referral to reproductive psychiatrist for severe/refractory cases. PMDD often improves after menopause or with pregnancy/breastfeeding (temporary).